MacroGenics: Oncology Opportunities In Play, But Investing Feels Like A Gamble
Source: SeekingAlpha
2026-04-10 12:51:41 ET
Investment Overview
MacroGenics ( MGNX ) is a Rockville, Maryland-based biotech, and an investment opportunity I am returning to, admittedly with some trepidation. Five years ago, I covered the company in a note for Seeking Alpha , assigning stock a Buy rating, and shares have fallen in value by >90% since....
Read the full article on Seeking Alpha
For further details see:
MacroGenics: Oncology Opportunities In Play, But Investing Feels Like A Gamble
MacroGenics Inc.
NASDAQ: MGNX
MGNX Trading
2.25% G/L:
$4.325 Last:
255,268 Volume:
$4.19 Open:
MGNX Latest News
May 14, 2026 04:01:00 pm
MacroGenics to Participate in the Stifel 2026 Virtual Targeted Oncology Forum
May 13, 2026 04:01:00 pm
MacroGenics Reports First Quarter 2026 Financial Results and Highlights Business Transformation
MGNX Stock Data
$110,069,846
55,034,923
1.49%
25
N/A
Biotechnology & Life Sciences
Healthcare
US
Rockville
